neurological disease

Merck Announces New Data Strengthening Evidence for Continued Safe and Effective MAVENCLAD® Use During the COVID-19 Pandemic

New analysis indicates a specific immune repopulation pattern in people treated with MAVENCLAD, which may contribute to their ability to…

Read More »